| |
 | John Michael Morris, Ph.D. |
John Michael Morris, Ph.D. was Director Scientific Affairs at the Health Products Regulatory Authority (HPRA) of Ireland, in Dublin, Ireland until his retirement at the end of 2015. Dr. Morris was formerly Pharmaceutical Director, IMB, responsible for the assessment of quality data (CMC data) and before that Senior Pharmacist at the Irish National Drug Advisory Board. Prior to this, he was a Research Pharmacist at Sterling Winthrop R&D. Dr. Morris obtained a Ph.D. from the University of Manchester (UK). Dr. Morris was the EU member of the ICH Q6A Expert Working Group, and in 2003 led the Group for the revision of the ICH Guideline Q3B. He was a member of the CPMP/CVMP Quality Working Party until 2003, and in 2004 was elected to the position of Chairman of the European Pharmacopoeia Commission. Currently he remains a member of the European Pharmacopoeia Commission and is still active in ICH being Rapporteur (Chair) and EU topic leader for Q4B-pharmacopoeial harmonization.
